Taking a biotech company public is one of the most demanding leadership experiences a CEO faces. The IPO preparation process runs simultaneously across legal, financial, regulatory, communications, governance, and investor relations dimensions, each with its own intensive preparation requirements and its own regulatory or market deadlines. The CEO must be personally engaged in many aspects of this process while simultaneously continuing to lead the business.
The biotech CEO who tries to personally manage every dimension of IPO preparation will be exhausted, underprepared in the areas that matter most, and distracted from the operational leadership the company needs during this critical transition period. A delegation playbook is the organizational tool that makes IPO preparation sustainable.
What the CEO Owns in IPO Preparation
Before building the delegation framework, define clearly what the biotech CEO must personally own during IPO preparation. These are the non-delegatable responsibilities:
The investor narrative. The CEO is the primary author of how the company’s story is told to public market investors: the science, the differentiation, the market opportunity, the team, and the strategic vision. While advisors and the communications team support the narrative development, the CEO must own and authentically deliver it.
Investor roadshow relationships. The CEO, typically alongside the CFO, leads the investor roadshow meetings where institutional investors make their investment decisions. These meetings require CEO presence, credibility, and the ability to respond to sophisticated investor questions in real time.
The S-1 registration statement. The CEO signs the S-1. They are legally accountable for its accuracy and completeness. While lawyers, the CFO, and communications teams draft and review the S-1, the CEO must understand it deeply enough to own it.
Senior underwriter and banker relationships. The CEO leads the bank selection process, maintains the primary relationship with the lead underwriter, and participates in the pricing discussion and final IPO decisions.
Governance and board readiness. The CEO is responsible for ensuring the board is appropriately constituted for a public company, including the addition of independent directors with public company governance experience.
Everything else in the IPO preparation process is a candidate for delegation.
Assigning the IPO Project Management Function
IPO preparation involves dozens of workstreams running in parallel over six to twelve months. Managing these workstreams requires a dedicated project management function.
Designate a Chief of Staff, VP of Finance with project management responsibilities, or an investment banking liaison as the IPO project manager. Their responsibilities include:
Maintaining the IPO preparation timeline and tracking progress against all workstreams. Coordinating across internal teams (finance, legal, HR, operations, communications) and external advisors (investment bankers, lawyers, auditors). Scheduling and preparing the CEO for all preparation meetings. Managing the organizational calendar to ensure preparation activities do not collide.
The CEO reviews project status at weekly check-ins with the IPO project manager, not by personally tracking every workstream.
Delegating Financial Preparation
Public company financial readiness involves extensive work: completing financial statement audits under PCAOB standards, establishing Sarbanes-Oxley compliance infrastructure, building investor-grade financial reporting systems, and constructing the financial projections and model that support the S-1.
The CFO owns this entire domain. The financial preparation team, supported by the external auditors and accounting advisors, manages the accounting work. The CEO reviews financial outputs at key milestones, understands the financial story well enough to present it credibly in investor meetings, and makes the strategic decisions about financial disclosure choices. They do not personally manage the accounting transformation process.
For the broader pharma and biotech CEO financial delegation framework, see pharma CEO delegation guide.
Delegating Legal and Compliance Preparation
Legal preparation for an IPO includes: S-1 drafting and the associated disclosure due diligence, securities law compliance, board governance documentation, equity plan design and registration, material contracts review, and ongoing compliance infrastructure development.
The General Counsel and outside securities counsel lead the legal workstream. The CEO participates in S-1 content discussions and review sessions, provides the business context needed for disclosure decisions, and makes the strategic judgment calls when disclosure choices have strategic implications.
The CEO does not manage the legal process, attend every document review session, or personally track compliance checklist items. That is legal counsel’s function.
Managing the Communications and Investor Relations Workstream
Communications for an IPO involves building the investor presentation, preparing the CEO for analyst and investor Q&A, managing the company’s pre-IPO communications within the SEC’s quiet period requirements, and establishing the public company communications infrastructure for after the IPO.
An Investor Relations Director or Head of Investor Relations should lead this workstream, working with the communications team and investor relations advisors. Their responsibilities include: developing the investor presentation drafts, preparing the CEO for roadshow presentations and Q&A, coordinating analyst relations, and managing the communications calendar around IPO milestones.
The CEO provides the strategic content that drives the investor narrative and delivers the final presentations. The communications and IR team handles the preparation, logistics, and infrastructure.
Governance and Board Development for IPO
Public company governance requirements are materially more demanding than private company requirements. The board must meet independence standards, committees must be appropriately constituted, and governance policies must reflect public company expectations.
A Corporate Governance Advisor or the General Counsel manages the governance readiness workstream: assessing current board composition against public company requirements, facilitating board member search and addition processes, developing governance policies, and preparing committee charters.
The CEO leads the board development effort at the relationship level: identifying and cultivating prospective independent directors, making the board composition decisions, and building relationships with new board members. The governance infrastructure preparation is managed by the legal and governance advisor team.
Maintaining Business Operations During IPO Preparation
One of the most significant risks of IPO preparation is that the process consumes so much leadership bandwidth that business operations suffer during the critical pre-IPO period. Investors are buying a story about the company’s future, which means clinical programs, regulatory progress, and commercial development must continue performing during the preparation period.
The CEO must maintain meaningful engagement with business operations even while managing IPO preparation demands. This requires aggressive delegation of IPO operational work to advisors and internal teams, so that the CEO can continue spending meaningful time on the business itself.
Build a weekly schedule that protects business leadership time: one-on-ones with the CMO, CSO, and COO, clinical program review, and strategic business decisions should not be displaced by IPO logistics. The IPO project manager and advisory teams should absorb the logistics; the CEO manages the substance.
Preparing the Leadership Team for Public Company Life
The transition from private to public company affects the entire leadership team, not just the CEO. Public company communication requirements, securities law constraints, disclosure obligations, and investor relation responsibilities create a new operating environment that leadership team members must understand.
Delegate the leadership team preparation to the General Counsel and outside securities counsel. They conduct training sessions for the leadership team on public company requirements, securities trading restrictions, disclosure obligations, and earnings communication protocols.
The CEO participates in leadership team preparation discussions at the strategic level, ensuring the team understands the behavioral changes required by public company status. The legal team delivers the operational training.
According to Harvard Business Review, biotech CEOs who maintain strong business operational engagement during IPO preparation achieve better post-IPO performance because they arrive at public market status with strong execution momentum, not just a compelling story.
Post-IPO Delegation Reset
IPO preparation creates temporary delegation patterns that may not be sustainable as ongoing public company operating norms. After the IPO, conduct a delegation reset: assess where the CEO is still spending time on activities that should be moved to the investor relations function, the CFO team, or the corporate governance infrastructure.
The post-IPO CEO’s role in investor relations, financial communication, and governance is ongoing but should be structured for sustainability, not the intensity of the IPO period itself.
See pharma commercial strategy for how commercial delegation evolves as a biotech company transitions from private to public status.
Conclusion
Biotech IPO preparation is an intense, multi-dimensional organizational undertaking that requires CEO leadership in the moments that matter most and delegation everywhere else. The CEO’s irreplaceable contributions are the investor narrative, the roadshow relationships, the financial story ownership, and the governance leadership that positions the company for public market accountability.
Build the delegation structure before the preparation process begins. Designate the project manager, engage the advisors, assign the functional workstream owners, and protect your business leadership time. Arrive at your IPO having led it without being consumed by it. That is the leadership achievement that sets up the public company you are about to become.
Related Reading
For further context, explore Delegation Playbook for Automotive CEO: Cost Reduction and Delegation Playbook for Automotive CEO: Crisis Management.